Neximmune Ownership
| NEXIDelisted Stock | USD 2.43 0.22 9.95% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Neximmune |
Neximmune Pink Sheet Ownership Analysis
About 17.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.38. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Neximmune recorded a loss per share of 24.11. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 19th of October 2023. NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. Neximmune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.The quote for Neximmune is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Neximmune contact Kristi RPh at 301 825 9810 or learn more at https://www.neximmune.com.Neximmune Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Neximmune insiders, such as employees or executives, is commonly permitted as long as it does not rely on Neximmune's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Neximmune insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jones Kristi over three months ago Acquisition by Jones Kristi of tradable shares of Neximmune at 0.01 subject to Rule 16b-3 | ||
Verstandig Grant over six months ago Acquisition by Verstandig Grant of 5430 shares of Neximmune at 1.23 subject to Rule 16b-3 | ||
Roemer Alan S over six months ago Conversion by Roemer Alan S of 12268 shares of Neximmune | ||
Roemer Alan S over a year ago Sale by Roemer Alan S of 3833 shares of Neximmune | ||
Stover Timothy over a year ago Neximmune exotic insider transaction detected | ||
Roemer Alan S over a year ago Acquisition by Roemer Alan S of 44983 shares of Neximmune subject to Rule 16b-3 | ||
Mathias Oelke over a year ago Acquisition by Mathias Oelke of 31948 shares of Neximmune subject to Rule 16b-3 |
Neximmune Outstanding Bonds
Neximmune issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Neximmune uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Neximmune bonds can be classified according to their maturity, which is the date when Neximmune has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| NextEra Energy Operating Corp BondUS65342QAB86 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| NextEra Energy Operating Corp BondUS65342QAL68 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Nexstar Escrow 5625 Corp BondUS65343HAA95 | View |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Neximmune Pink Sheet
If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |